Evidence map›Paper›PMID 40278287›Full record

ArticleMarine drugs2025

Advanced Strategies for Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Production: PHA Synthase Homologous Overexpression in the Extremophile

Alexandra Simica, Yolanda Segovia, Alicia Navarro-Sempere, Rosa María Martínez-Espinosa, Carmen Pire

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Recent Advances in Understanding Bio-Compounds from Haloarchaea.Journal of microbiology and biotechnology · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexandra SimicaMultidisciplinary Institute for Environmental Studies "Ramón Margalef", University of Alicante, Ap. 99, E-03080 Alicante, Spain.
Yolanda SegoviaBiotechnology Department, Faculty of Science, University of Alicante Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0003-1727-2603
Alicia Navarro-SempereBiotechnology Department, Faculty of Science, University of Alicante Ap. 99, E-03080 Alicante, Spain.
Rosa María Martínez-EspinosaMultidisciplinary Institute for Environmental Studies "Ramón Margalef", University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0003-2679-135X
Carmen PireMultidisciplinary Institute for Environmental Studies "Ramón Margalef", University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0002-8956-4851

Funding

European Commission 953214Generalitat Valenciana, Spain CIACIF/2023/337University of Alicante, Spain UAFPU22-28University of Alicante, Spain VIGROB-309
6 · The paper itself

Abstract

Bioplastics such as poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) are promising alternatives to conventional plastics. However, the high production cost limits their industrial application. In this study, PHBV production was optimized in

Indexed as

AcyltransferasesHaloferax mediterraneiPolyestersCulture MediaNitrogenPolyhydroxybutyratesAcyltransferasesCulture MediaNitrogenpoly(3-hydroxyalkanoic acid) synthasepoly(3-hydroxybutyrate)-co-(3-hydroxyvalerate)PolyestersPolyhydroxybutyrateshaloarchaeaHaloferax mediterraneioverexpressionPHAPHA synthasePHBV

Identifiers

PMID40278287
PMCPMC12028471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.